Question Bank › The knock on the company is going stale

The knock on the company is going stale

The knock on the company is going stale: this quarter's own facts cut against the standing doubt

Calls Tested
287
Answered YES
68
Hit Rate
23.7%
rare by design

Magnite, Inc. (MGNI) — this company's answers

NO on the Q1 2022 call 2022-05-04 D
The model's full reasoning — Q1 2022 call → NO我们根据提供的财报电话会议记录,分析是否存在一个明确的、公司特定的疑虑,并且本季度的实际运营证据是否反驳了该疑虑。 首先,寻找疑虑。在电话会议中,分析师和公司管理层多次提到一些主题。例如,关于SSP(卖方平台)的相关性,特别是当卖家可以直接连接买家时,SSP是否还有价值。管理层在开场白中直接回应了这个问题,说“最近,有人质疑卖方平台的相关性……我们并不认为这些连接是威胁”,并进一步阐述SSP变得更加重要。这显然是一个公司特定的疑虑:市场可能认为SSP会被绕过,导致需求下降。管理层用战略观点回应,但这是否有本季度的实际证据? 另外,关于CTV增长、政治广告、OpenPass等也有讨论。但最突出的疑虑似乎是关于SSP的长期相关性,以及公司能否在直接连接的趋势中保持地位。管理层在回答中提到了与GroupM的合作、与出版商的对话等,但这些都是计划或关系,而非本季度具体发生的运营数据。 另一个可能的疑虑是盈利能力。公司有净亏损,但调整后EBITDA为正且增长。管理层提到“我们预计全年收入ex-TAC将远高于5亿美元”,并给出了Q2指引。但疑虑是否明确?分析师没有直接问“你们什么时候盈利”,但管理层在回答中强调了“我们有一个非常有吸引力的财务模型,并期望从收入增长到调整后EBITDA利润率扩张再到自由现金流的流动”。这可能是对盈利能力的回应,但更多是展望。 再仔细看,分析师Laura Martin问关于CTV和Netflix/Disney添加广告层,管理层回答“没有比这更好的了”,并解释这是积极的。这似乎不是疑虑。 分析师Jason Kreyer问关于Q2指引的强劲,管理层提到了乌克兰影响和恢复。这也不是公司特定疑虑。 分析师Shyam Patil问关于OpenPass和独立SSP的价值,管理层详细回应了。这确实是一个疑虑:OpenPass可能绕过SSP。管理层说“我们并不认为这些连接是威胁”,并解释了为什么SSP更有价值。但本季度是否有实际证据?管理层提到了“我们与GroupM的优先合作伙伴关系”作为例子,但这是宣布的合作,不是本季度发生的运营结果。另外,管理层提到“我们最近宣布的与GroupM的优先合作伙伴关系”,但这是宣布,不是实际收入。 另一个可能的疑虑是依赖大客户,比如Disney。分析师Jason Kreyer问关于Disney关系,管理层说“关系仍然非常牢固”,并提到续约即将到来,但“我们没有看到任何实质性变化”。这似乎不是疑虑,而是确认。 再考虑“损失是否会结束”的疑虑。公司有净亏损,但调整后EBITDA为正。管理层在电话中强调了调整后EBITDA增长和自由现金流预期。但分析师没有直接质疑亏损,管理层也没有直接回应。 最明显的公司特定疑虑似乎是关于SSP在直接连接趋势下的相关性。管理层在开场白中直接回应了这一点,说“我们并不认为这些连接是威胁”,并详细阐述了为什么SSP更有价值。但本季度的实际证据是什么?管理层提到了“我们最近宣布的与GroupM的优先合作伙伴关系”作为例子,但这是宣布,不是实际收入。另外,管理层提到了“我们与出版商的对话”和“对第一方数据的兴趣”,但这些是定性描述,不是具体数字。 此外,管理层提到了“我们继续看到CTV的强劲增长”,但这是整体增长,不是针对疑虑的。 再考虑是否有其他疑虑,比如对单一市场的依赖?没有。 因此,疑虑存在,但本季度的证据是否反驳了它?管理层用战略论点回应,但缺乏具体运营数据。例如,没有提到实际的新客户签约、收入增长来自直接连接等。管理层说“我们看到了这些连接作为SSP变得更有价值的迹象”,但这是观点,不是事实。 另外,关于盈利能力,管理层给出了Q2指引,但这是预测,不是已发生。 所以,我认为疑虑存在,但本季度的证据主要是管理层的信心和战略,而非具体运营事实。因此,答案应为NO。 但再仔细看,管理层在回答OpenPass问题时说:“我们看到了这些连接作为SSP变得更有价值的迹象”,并提到了“我们与GroupM的优先合作伙伴关系”作为例子。这算不算实际证据?GroupM合作是宣布的,但可能已经生效?电话会议是5月4日,合作可能已经宣布,但具体收入影响未知。管理层没有提供具体数字。 另外,管理层提到了“我们最近收购了Nth Party和Carbon”,但这是收购,不是运营。 因此,我认为没有足够的本季度实际运营证据来反驳疑虑。所以答案应为NO。 但让我们确认一下,是否有其他疑虑?比如,关于CTV增长是否可持续?管理层给出了Q2指引,但这是预测。 总之,我认为疑虑是存在的,但反驳证据主要是战略和计划,而非已发生的运营事实。因此,答案NO。

← Back to the full MGNI analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: Reading this call as a whole, can you identify ONE well-defined DOUBT that has clearly been weighing on how this company is perceived — a standing knock evident from the transcript itself, such as skepticism that its losses will ever end, that its main product or model will find repeat demand, that its legacy business's decline will swamp everything else, that it depends too heavily on one customer, market, or financing source, or another comparable company-specific concern — AND does the CURRENT PERIOD'S OWN OPERATING EVIDENCE, as recounted by management, move clearly AGAINST that doubt? Answer YES when BOTH halves come through in the transcript, in whatever form fits the business: (1) A STANDING, COMPANY-SPECIFIC DOUBT IS VISIBLE ON THE CALL. The transcript itself shows that a particular concern has hung over this company — through analysts returning to it, management acknowledging what skeptics or investors have worried about, or management plainly addressing a question it knows the audience carries (can this business make money, will anyone buy this at scale, will the decline stop, can they fund themselves, will the big customer stay). The doubt must be specific to this company's situation, not generic macro gloom, and must read as something that predates this quarter rather than arising on this call. (2) THIS PERIOD'S REAL ACTIVITY CUTS AGAINST IT. Management recounts concrete things that actually happened in the recent period — actual orders, customers returning or expanding, real revenue or volumes where there had been little, losses narrowing because of how the business itself is now running, the doubted product performing in real use, the feared departure or decline not occurring while something better did — described with enough operating substance that the contradiction rests on observed events rather than on reassurance, plans, or projections. The evidence need not fully settle the doubt; what matters is that the current period's facts point the other way and management engages the doubt with those facts. Answer NO if no company-specific doubt is discernible — an ordinarily healthy company reporting a routine quarter. NO if the doubt exists but management answers it mainly with confidence, vision, targets, or hoped-for improvements rather than with things that already happened. NO if the period's evidence actually confirms the doubt (the losses widened, the decline continued, the customer left) and management is excusing it. NO if the contrary evidence is a one-time item, an asset sale, a financing, or something management itself treats as non-recurring rather than the business operating differently. NO if the doubt and the evidence never connect — strong facts reported on one topic while the standing concern sits elsewhere untouched. NO if the doubt appears only as boilerplate risk language or an analyst aside that management never engages. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
CRGO Freightos Limited Q1 2024 2024-05-20 C+
IFS Intercorp Financial Services Inc. Q1 2024 2024-05-14 C+
PRA ProAssurance Corporation Q1 2024 2024-05-11 D
LTRX Lantronix, Inc. Q3 2024 2024-04-29 C
ASB Associated Banc-Corp Q1 2024 2024-04-25 A
GL Globe Life Inc. Q1 2024 2024-04-23 F
ASM Avino Silver & Gold Mines Ltd. Q4 2023 2024-03-21 C+
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
HP Helmerich & Payne, Inc. Q1 2024 2024-01-30 C
PFE Pfizer Inc. Q4 2023 2024-01-30 F
QTRX Quanterix Corporation Q3 2023 2023-11-07 B
ALL The Allstate Corporation Q3 2023 2023-11-02 C+
DASH DoorDash, Inc. Q3 2023 2023-11-01 C+
PTN Palatin Technologies, Inc. Q4 2023 2023-09-29 D
BZUN Baozun Inc. Q2 2023 2023-08-28 D
GVP GSE Systems, Inc. Q1 2023 2023-05-15 D
BXSL Blackstone Secured Lending Fund Q1 2023 2023-05-10 A
FTHM Fathom Holdings, Inc. Q1 2023 2023-05-10 C
SPIR Spire Global, Inc. Q1 2023 2023-05-10 B
SBRA Sabra Health Care REIT, Inc. Q1 2023 2023-05-04 B
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
VRE Veris Residential, Inc. Q4 2022 2023-02-22 D
TOST Toast, Inc. Q4 2022 2023-02-16 C+
PKOH Park-Ohio Holdings Corp. Q3 2022 2022-11-13 B
CLSD Clearside Biomedical, Inc. Q3 2022 2022-11-09 C
SIBN SI-BONE, Inc. Q3 2022 2022-11-07 C+
CHE Chemed Corporation Q3 2022 2022-11-01 B+
YMM Full Truck Alliance Co. Ltd. Q2 2022 2022-08-25 C+
EXFY Expensify, Inc. Q2 2022 2022-08-12 D
WD Walker & Dunlop, Inc. Q2 2022 2022-08-09 C+
DM Desktop Metal, Inc. Q2 2022 2022-08-08 F
XHR Xenia Hotels & Resorts, Inc. Q2 2022 2022-08-05 A
LIN Linde plc Q2 2022 2022-07-28 B+
CME CME Group Inc. Q2 2022 2022-07-27 B
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
SE Sea Limited Q1 2022 2022-05-17 F
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
OPK OPKO Health, Inc. Q1 2022 2022-05-09 D
FARM Farmer Bros. Co. Q3 2022 2022-05-07 D
BFIN BankFinancial Corporation Q1 2022 2022-05-06 A
BXP Boston Properties, Inc. Q1 2022 2022-05-03 A
STC Stewart Information Services Corporation Q1 2022 2022-04-29 C+
LOW Lowe's Companies, Inc. Q3 2021 2021-11-17 B+
CYBR CyberArk Software Ltd. Q3 2021 2021-11-04 B+
IPGP IPG Photonics Corporation Q3 2021 2021-11-02 C
SXC SunCoke Energy, Inc. Q3 2021 2021-11-01 A
EMR Emerson Electric Co. Q3 2021 2021-08-04 B+
EEX Emerald Holding, Inc. Q2 2021 2021-08-01 C+
GECC Great Elm Capital Corporation Q3 2018 2018-11-13 B
UMH UMH Properties, Inc. Q3 2018 2018-11-02 C+
FOSL Fossil Group, Inc. Q1 2018 2018-05-08 C
BCOV Brightcove Inc. Q1 2018 2018-04-26 B+
AVT Avnet, Inc. Q2 2018 2018-01-25 B
PII Polaris Inc. Q3 2017 2017-10-24 C+
GNTX Gentex Corporation Q3 2017 2017-10-20 B
MTG MGIC Investment Corporation Q3 2017 2017-10-18 B+
LIND Lindblad Expeditions Holdings, Inc. Q2 2017 2017-08-06 C
BIIB Biogen Inc. Q2 2017 2017-07-25 B
CAG Conagra Brands, Inc. Q2 2017 2016-12-22 C+
WYY WidePoint Corporation Q3 2016 2016-11-09 D
ULBI Ultralife Corporation Q3 2016 2016-10-29 C+
ARAY Accuray Incorporated Q4 2016 2016-08-17 B
GES Guess?, Inc. Q1 2017 2016-05-25 F
RCL Royal Caribbean Cruises Ltd. Q1 2016 2016-04-29 C+
DD DuPont de Nemours, Inc. Q1 2016 2016-04-26 B+
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C

How the model reasoned

BRX · Q1 2023 → YESThe question asks if there's a standing company-specific doubt visible on the call, and if this period's operating evidence cuts against it. YES The standing doubt is the skepticism that tenant disruptions (especially bankruptcies like Bed Bath) will create occupancy pressure and throw markets out of equilibrium, given the recaptured space and potential for more filings. This is visible in analyst questions (Todd Thomas on Bed Bath impact and market equilibrium; others circling back on bad debt 75-110 bps and bankruptcy activity) and management's acknowledgment that "recent retailer bankruptcy announcements will result in occupancy pressure" while noting they've "been preparing for the last several quarters." This period's evidence cuts against it: record 94% total occupancy (up sequentially in a seasonally weak quarter), small-shop at 89.
CME · Q2 2022 → YESThe question is: Identify ONE well-defined DOUBT that has been weighing on the company, and see if the current period's operating evidence moves against that doubt. YES The standing doubt is the perceived risk that the legacy NEX Group businesses (BrokerTec and EBS) would continue to show range-bound revenue and fail to deliver meaningful growth despite a constructive macro backdrop, as directly raised by Alex Blostein. Management engages this concern head-on by recounting concrete operating evidence from 2Q: BrokerTec US treasuries ADV up 14% YoY, US repo up 25% YoY, EU repo up 14% YoY, plus $4.5 billion in new cross-sell volume from previously non-trading clients and record RV trading volumes of $2.4 billion; 90% of the migration to Globex is complete, with the remaining EBS migration also finished and system enhancements underway.
BXSL · Q1 2023 → YESThe question asks if there's a standing company-specific doubt visible in the transcript, and if this period's operating evidence moves against it. YES The standing doubt visible in the transcript is the skepticism that BXSL’s credit performance will be materially worse than the broader private-credit market because of its exposure to higher-rate environments and the “tails” of the portfolio (i.e., the small slice of companies whose interest-coverage ratios could fall below 1× when 5 % rates are stress-tested). Management itself flags this concern by noting that “it is less about averages… much more about the tails” and that investors keep asking about the percentage of the portfolio below 1× ICR. This quarter’s operating evidence directly counters that doubt: - 0.

More from the question bank

Acted like it's already biggerBetting on a claim they haven't proven yetMoney already collected for work not yet donNew faces on the callThe streak is aliveCommitted past the numbersAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.